Prophylaxis against Toxoplasma gondii disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation Profilaxis de toxoplasmosis en niños y adultos sometidos a trasplante de órganos sólidos y precursores hemato
Author
dc.contributor.author
Payá, Ernesto
Author
dc.contributor.author
Noemí, Isabel
Author
dc.contributor.author
Tassara, Renzo
Author
dc.contributor.author
Catalán, Paula
Author
dc.contributor.author
Avilés, Carmen L.
Admission date
dc.date.accessioned
2019-03-15T16:03:29Z
Available date
dc.date.available
2019-03-15T16:03:29Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Revista Chilena de Infectologia, Volumen 29, Issue SUPPL.1, 2018, Pages 37-39
Identifier
dc.identifier.issn
07161018
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165843
Abstract
dc.description.abstract
Toxoplasmosis is a widely distributed zoonosis produced by the parasite T. gondii. In Chile the seroprevalence has been estimated between 20-37% in general population. Defined risk groups acquire or reactivate the infection by T. gondii in patients undergoing SOT and HSCT are: heart transplant or heart-lung with D (+) and R (-), allogeneic HSCT with R (+), HSCT with cord cells, GVHD, history of previous clinical toxoplasmosis and use of corticosteroids for prolonged periods or in high doses. Hand washing, hygiene in food handling and weekly post-transplant surveillance since day 15 post transplant for six months, are universally recommended. All patients with SOT and HSCT, regardless of risk, should receive prophylaxis with cotrimoxazole and require no another specific prophylaxis against T. gondii (A2). It is particularly important in high-risk patients who cannot receive cotrimoxazole prophylaxis establish specific alternative against T. gondii (B3).
Prophylaxis against Toxoplasma gondii disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation Profilaxis de toxoplasmosis en niños y adultos sometidos a trasplante de órganos sólidos y precursores hemato